EXTON,
Pa., Oct. 9, 2024 /PRNewswire/ -- West
Pharmaceutical Services, Inc. (NYSE: WST), a global leader in
innovative solutions for injectable drug administration, is
pleased to announce that it has been awarded the Heart of Pharma
Award at the 2024 CPHI Awards for its partnership with Fox Chase
Cancer Center, a part of the Temple
University Health System. This award recognizes companies,
individuals, and initiatives which nurture philanthropic, ethical
and community-based ventures. West was announced the winner during
an awards ceremony on the opening night of CPHI Worldwide on
October 8 in Milan, Italy.
West has been a philanthropic partner of Fox Chase Cancer
Center, a Philadelphia-based
comprehensive cancer center committed to clinical excellence,
research expertise, and community health, for over two
decades. In 2021, West pledged to support a next-generation
mobile screening unit, building on Fox
Chase's three decades of experience as a leader in mobile
cancer screening. With the help of funds raised by West team
members, Fox Chase announced a new
state-of-the-art mobile screening unit sponsored by West that will
provide services later this year. This mobile screening van
will increase Fox Chase's capacity
to bring cancer screenings directly into communities with limited
access to healthcare. The new unit will offer screening for
more types of cancer, 3D mammography, and new initiatives, like
vaccine distribution, phlebotomy, and collection of biospecimens
and population data to advance cancer research.
"We are honored to receive this recognition from CPHI and
grateful to serve as a partner with Fox Chase Cancer Center,
helping to make a difference in the fight against cancer," said
Eric Green, West President and CEO.
"West is proud to be by the side of research centers like
Fox Chase and remain committed
together to improving the overall health and wellness of the
communities we serve."
"On behalf of the faculty, staff and patients at Fox Chase
Cancer Center, I would like to offer my sincere and heartfelt
congratulations on this award," said Robert
Uzzo, MD, MBA, FACP, Fox Chase Cancer Center President &
CEO. "As we work to fulfill our mission for our community,
philanthropy plays a huge role, and West has always been one of our
most generous partners. We are grateful for their support."
For more information about CPHI Worldwide, please visit:
At the heart of Pharma | CPHI Milan
About West
West Pharmaceutical Services, Inc. is a leading provider of
innovative, high-quality injectable solutions and services. As a
trusted partner to established and emerging drug developers, West
helps ensure the safe, effective containment and delivery of
life-saving and life-enhancing medicines for patients. With over
10,000 team members across 50 sites worldwide, West helps support
our customers by delivering approximately 43 billion components and
devices each year.
Headquartered in Exton,
Pennsylvania, West in its fiscal year 2023 generated
$2.95 billion in net sales. West is
traded on the New York Stock Exchange (NYSE: WST) and is included
on the Standard & Poor's 500 index. For more information, visit
www.westpharma.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/west-wins-heart-of-pharma-award-at-2024-cphi-pharma-awards-302270777.html
SOURCE West Pharmaceutical Services, Inc.
